Objectives: Several highly transmissible and virulent genotypes of Pseudomonas aeruginosa have been recognised in the UK including the Liverpool, Midlands and Manchester genotypes and Clone C. It has been suggested that patients colonised with a transmissible genotype may have a poorer prognosis and increased treatment needs. We describe the clinical features of patients who isolated P. aeruginosa clone C in our paediatric CF centre. Methods: The hospital microbiology database was used to identify the patients. There were five isolations from five patients (four boys, aged 1−12 years, mean 4.4 years). All isolations were new, obtained from cough swabs performed at routine clinics. Four patients had new wet cough, one of whom had reduced lung function. One patient had no new clinical features. Four patients received intravenous antibiotics and one patient oral antibiotics. The organisms were sensitive to standard antipseudomonal antibiotics. The patients were removed from clinic and seen separately until confirmed negative for infection. Four patients remained free of infection in the one year following isolation. Three patients underwent bronchoscopy and BAL was culture negative. One patient had subsequent second isolation in the same year. The frequency of pre and post pseudomonas isolation respiratory exacerbations remains similar. All five are on conventional physiotherapy with no additional requirement of pharmacological treatment of chest disease. Conclusion: P. aeruginosa clone C isolates in our centre are currently sensitive to standard antibiotics. We have found no evidence of increased virulence or that the organism is overtly transmissible.
